Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Development of an immune or autoimmune response involves T-cell activation in lymphoid organs and subsequent migration to peripheral tissues. Here we show that T-cell-specific ablation of the kinase TBK1 promotes T-cell activation but causes retention of effector T cells in the draining lymph node in a neuroinflammatory autoimmunity model, experimental autoimmune encephalomyelitis (EAE). At older ages, the T-cell-conditional TBK1-knockout mice also spontaneously accumulate T cells with activated phenotype. TBK1 controls the activation of AKT and its downstream kinase mTORC1 by a mechanism involving TBK1-stimulated AKT ubiquitination and degradation. The deregulated AKT-mTORC1 signalling in turn contributes to enhanced T-cell activation and impaired effector T-cell egress from draining lymph nodes. Treatment of mice with a small-molecule inhibitor of TBK1 inhibits EAE induction. These results suggest a role for TBK1 in regulating T-cell migration and establish TBK1 as a regulator of the AKT-mTORC1 signalling axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent studies have demonstrated critical roles for TBK1 and/or IKK ε in regulation of activity of numerous immune cell types, including T cells 21 , B cells 22,23 , dendritic cells 24 , and macrophages 25,26 .”
From Targeting TBK1 to overcome resistance to cancer immunotherapy (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredIn the citing paper
“In keeping with this, Tbk1 deletion disrupts the migration of T-cells [216] that may exert anti-inflammatory effects in ALS models [192,217].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [216]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452 · cited 1×
“The T-cell priming and differentiation are governed by signal transduction mediated by the TCR and a costimulatory molecule, CD28, as well as cytokine signals 6 .”
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · cited 2×
“In vitro T-cell migration assays were performed using a 24-well plate Boyden chamber essentially as previously described 33 .”
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740 · cited 1×
“The central nervous system (CNS) is an organ of a number of autoimmune and inflammatory disorders, including multiple sclerosis, a disease characterized by chronic inflammation, demyelination, and neuronal damage 2 .”
Triggering the Interferon Antiviral Response Through an IKK-Related Pathway
Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G.-P., Lin, R., & Hiscott, J. (2003) · Science · doi:10.1126/science.1081315 · Cited by 1,661
Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1716 · Cited by 1,206 · cited 1×
“5) 22–24 .”
Regulation and function of mTOR signalling in T cell fate decisions
Chi, H. (2012) · Nature Reviews Immunology · doi:10.1038/nri3198 · Cited by 1,035
Autoimmune T cell responses in the central nervous system
Goverman, J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2550 · Cited by 1,030 · cited 1×
“It is generally believed that in MS and EAE, autoimmune T cells are primed by myelin-specific antigens and then migrate across the blood-brain barrier to enter the CNS, where they become reactivated and mediate inflammation and neuronal damage 4,5 .”
Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice
Arbonés, M. L., Ord, D. C., Ley, K., Ratech, H., Maynard-Curry, C., Otten, G., Capon, D. J., & Teddert, T. F. (1994) · Immunity · doi:10.1016/1074-7613(94)90076-0 · Cited by 831 · cited 1×
“2d), they did not have a defect in T-cell homing to the lymph nodes as shown for the CD62L-deficient mice 19,20 .”
The integration of T cell migration, differentiation and function
Masopust, D., & Schenkel, J. M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3442 · Cited by 627 · cited 1×
“Newly activated T cells express low levels of the factors involved in T-cell migration, particularly the transcription factor KLF2 and its target gene product S1PR1, which is correlated with the lymphoid retention of the T cells 39 .”
Cited by
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Jenkins, R. W., Aref, A. R., Lizotte, P. H., Ivanova, E., Stinson, S., Zhou, C. W., Bowden, M., Deng, J., Liu, H., Miao, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0833 · Cited by 594
“To determine if MDOTS profiling predicted in vivo response to dual TBK1/IKKε inhibition, BALB/c mice bearing CT26 tumors were treated with Cmpd 1 ± anti–PD-L1 (Fig.”
BackgroundInfluentialKinase inhibition in autoimmunity and inflammation
Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431
Oduro, P. K., Zheng, X., Wei, J., Yang, Y., Wang, Y., Zhang, H., Liu, E., Gao, X., Du, M., & Wang, Q. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.011 · Cited by 339
Inflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
“Interestingly, when challenged with the EAE model, ablating TBK1 in T cells led to retention of effector T cells in the draining lymph nodes, resulting in decreased numbers of T cells infiltrating into the brain, and a less severe disease phenotype [165].”
Background
Metadata
- Authors
- Yu, J., Zhou, X., Chang, M., Nakaya, M., Chang, J.-H., Xiao, Y., William Lindsey, J., Dorta-Estremera, S., Cao, W., Zal, A., Zal, T., & Sun, S.-C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Fukui (JP)
- Corresponding author
- Sun, Shao-Cong
- ORCID
- Venue
- Nature Communications
- Published
- 2015-01-21
- Volume
- 6
- Issue
- 1
- Pages
- 6074-6074
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4302769
- OpenAlex
- W1963961512
- Cited by
- 118
- References
- 53
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 18 · 2023: 8 · 2022: 8 · 2021: 13 · 2020: 9 · 2019: 12 · 2018: 12 · 2017: 10 · 2016: 10 · 2015: 2
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (AI064639)
- University of Texas MD Anderson Cancer Center (P30-CA-016672, AI057555, AI104519)
- National Cancer Institute (R01CA181184, P30CA016672)
- National Institute of General Medical Sciences (GM84459, R01GM084459)
- National Institute of Allergy and Infectious Diseases (AI064639, R01AI057555, R37AI064639, R01AI064639, R01AI104519, AI104519, AI057555)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- TBK1, T cell activation, T cell migration, neuroinflammation, experimental autoimmune encephalomyelitis, Akt, mTORC1, draining lymph nodes, TBK1 inhibitors, autoimmunity
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Cell Movement, Cell Separation, Central Nervous System, Encephalomyelitis, Autoimmune, Experimental, Female, Gene Expression Regulation, Humans, Lymphocyte Activation, Macrophages, Male, Mice, Inbred C57BL, Orthomyxoviridae, Phenotype, Phosphorylation, T-Lymphocytes, Signal Transduction, CD4-Positive T-Lymphocytes, Autoimmunity, Protein Serine-Threonine Kinases, Mice, Knockout, CD8-Positive T-Lymphocytes, Jurkat Cells, Multiprotein Complexes, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation. https://app.cochat.ai/papers/10.1038/ncomms7074
- The paper
- Yu, J., Zhou, X., Chang, M., Nakaya, M., Chang, J.-H., Xiao, Y., William Lindsey, J., Dorta-Estremera, S., Cao, W., Zal, A., Zal, T., & Sun, S.-C. (2015). Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation. Nature Communications. https://doi.org/10.1038/ncomms7074
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.